BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17868815)

  • 1. Cardiovascular prevention in asymptomatic diabetic patients.
    Boyar A
    J Am Coll Cardiol; 2007 Sep; 50(12):1203; author reply 1204. PubMed ID: 17868815
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of prognosis in chronic coronary artery disease.
    Bateman TM; Prvulovich E
    Heart; 2004 Aug; 90 Suppl 5(Suppl 5):v10-5. PubMed ID: 15254004
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular mechanisms of diabetic cardiovascular disease.
    Hupfeld CJ; Wong GA
    Prev Cardiol; 2002; 5(4):183-7. PubMed ID: 12417827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of stress single-photon emission computed tomography imaging in asymptomatic patients with diabetes.
    Navare SM; Heller GV
    Am Heart J; 2004 May; 147(5):753-5. PubMed ID: 15131525
    [No Abstract]   [Full Text] [Related]  

  • 5. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association.
    Skyler JS; Bergenstal R; Bonow RO; Buse J; Deedwania P; Gale EA; Howard BV; Kirkman MS; Kosiborod M; Reaven P; Sherwin RS; ; ;
    J Am Coll Cardiol; 2009 Jan; 53(3):298-304. PubMed ID: 19147051
    [No Abstract]   [Full Text] [Related]  

  • 6. Yield of stress single-photon emission computed tomography in asymptomatic patients with diabetes.
    Miller TD; Rajagopalan N; Hodge DO; Frye RL; Gibbons RJ
    Am Heart J; 2004 May; 147(5):890-6. PubMed ID: 15131547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of atorvastatin in the prevention of cardiovascular events in diabetic patients: a French adaptation of CARDS.
    Lafuma A; Colin X; Solesse A
    Arch Cardiovasc Dis; 2008 May; 101(5):327-32. PubMed ID: 18656091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory Strategies to Prevent Diabetic Cardiovascular Disease.
    Jialal I; Devaraj S
    Clin Pharmacol Ther; 2015 Aug; 98(2):121-3. PubMed ID: 25732108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Should one prescribe aspirin for all diabetics?].
    Passa P
    Diabetes Metab; 1997 Dec; 23(6):554-6. PubMed ID: 9496565
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacogenomics in prevention of diabetic cardiovascular disease: utilization of the haptoglobin genotype in determining benefit from vitamin E.
    Levy AP; Blum S
    Expert Rev Cardiovasc Ther; 2007 Nov; 5(6):1105-11. PubMed ID: 18035926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and management of cardiovascular disease in patients with diabetes mellitus: an evidence base.
    Yudkin JS; Blauth C; Drury P; Fuller J; Henley J; Lancaster T; Lankester J; Lean M; Pentecost B; Press V; Rothman D
    Diabet Med; 1996 Sep; 13(9 Suppl 4):S101-21. PubMed ID: 8894461
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anti-diabetic therapy and cardiovascular risk].
    Mannucci E
    G Ital Cardiol (Rome); 2014 Dec; 15(12 Suppl 2):3S. PubMed ID: 25623544
    [No Abstract]   [Full Text] [Related]  

  • 13. New drugs for the treatment of diabetes mellitus: part I: Thiazolidinediones and their evolving cardiovascular implications.
    McGuire DK; Inzucchi SE
    Circulation; 2008 Jan; 117(3):440-9. PubMed ID: 18212301
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnosis of coronary artery disease by radionuclide myocardial perfusion imaging.
    Loong CY; Anagnostopoulos C
    Heart; 2004 Aug; 90 Suppl 5(Suppl 5):v2-9. PubMed ID: 15254003
    [No Abstract]   [Full Text] [Related]  

  • 15. Managing lipid levels in diabetes beneficial but requires clinical judgment.
    Trubo R
    JAMA; 2005 Aug; 294(6):670. PubMed ID: 16091562
    [No Abstract]   [Full Text] [Related]  

  • 16. Should you put all diabetic patients on statins?
    Leiter LA
    J Fam Pract; 2007 Apr; 56(4):294-300. PubMed ID: 17403328
    [No Abstract]   [Full Text] [Related]  

  • 17. Statin power.
    Diabetes Forecast; 2008 Apr; 61(4):28. PubMed ID: 18478640
    [No Abstract]   [Full Text] [Related]  

  • 18. Baseline characteristics of the patient population in the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus (SAVOR)-TIMI 53 trial.
    Mosenzon O; Raz I; Scirica BM; Hirshberg B; Stahre CI; Steg PG; Davidson J; Ohman P; Price DL; Frederich B; Udell JA; Braunwald E; Bhatt DL
    Diabetes Metab Res Rev; 2013 Jul; 29(5):417-26. PubMed ID: 23564755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes mellitus impairs myocardial oxygen metabolism even in non-infarct-related areas in patients with acute myocardial infarction.
    Toyoda K; Nakano A; Fujibayashi Y; Yonekura Y; Ueda T; Lee JD
    Int J Cardiol; 2007 Feb; 115(3):297-304. PubMed ID: 16899310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Restrengthening the concepts of comprehensive prevention and therapies of multiple cardiovascular risk factors in type 2 diabetes mellitus].
    Li XJ
    Zhonghua Nei Ke Za Zhi; 2013 Jul; 52(7):551-3. PubMed ID: 24266993
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.